OA10192A - Bmp-10 compositions - Google Patents

Bmp-10 compositions Download PDF

Info

Publication number
OA10192A
OA10192A OA60736A OA60736A OA10192A OA 10192 A OA10192 A OA 10192A OA 60736 A OA60736 A OA 60736A OA 60736 A OA60736 A OA 60736A OA 10192 A OA10192 A OA 10192A
Authority
OA
OAPI
Prior art keywords
bmp
seq
sequence
dna
amino acid
Prior art date
Application number
OA60736A
Other languages
English (en)
Inventor
Anthony J Celeste
John M Wozney
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst filed Critical Genetics Inst
Publication of OA10192A publication Critical patent/OA10192A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
OA60736A 1993-05-12 1995-11-10 Bmp-10 compositions OA10192A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6169593A 1993-05-12 1993-05-12

Publications (1)

Publication Number Publication Date
OA10192A true OA10192A (en) 1996-12-18

Family

ID=22037505

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60736A OA10192A (en) 1993-05-12 1995-11-10 Bmp-10 compositions

Country Status (12)

Country Link
EP (1) EP0698095B1 (fr)
JP (1) JPH09501305A (fr)
KR (1) KR100231640B1 (fr)
AT (1) ATE265529T1 (fr)
AU (1) AU677849B2 (fr)
BR (1) BR9406716A (fr)
CA (1) CA2161807A1 (fr)
DE (1) DE69433742T2 (fr)
FI (1) FI955420A (fr)
NO (1) NO954525D0 (fr)
OA (1) OA10192A (fr)
WO (1) WO1994026893A1 (fr)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20004692U1 (de) 2000-03-14 2001-07-26 Sofamor Danek Gmbh Wirbelimplantat zum Einschrauben in einen Wirbelzwischenraum
DE69433530T2 (de) * 1993-05-12 2005-01-05 Genetics Institute, LLC, Cambridge Bmp-11 zusammensetzungen
US5906827A (en) * 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
US5846770A (en) * 1994-11-22 1998-12-08 Genetics Institute, Inc. DNA molecules encoding human chordin
US5645084A (en) * 1995-06-07 1997-07-08 Danek Medical, Inc. Method for spinal fusion without decortication
US5635372A (en) * 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions
AU699918B2 (en) 1995-06-05 1998-12-17 Genetics Institute, Llc Methods and compositions for healing and repair of connective tissue attachment
US5902785A (en) * 1995-06-06 1999-05-11 Genetics Institute, Inc. Cartilage induction by bone morphogenetic proteins
US6423095B1 (en) 1995-10-16 2002-07-23 Sdgi Holdings, Inc. Intervertebral spacers
US5989289A (en) 1995-10-16 1999-11-23 Sdgi Holdings, Inc. Bone grafts
US5700774A (en) * 1996-03-26 1997-12-23 Genetics Institute, Inc. Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide, and methods of inducing cartilage by administration of same
US5965403A (en) 1996-09-18 1999-10-12 Genetics Institute, Inc. Nucleic acids encoding bone morphogenic protein-16 (BMP-16)
JP2000507484A (ja) 1996-10-23 2000-06-20 エスディージーアイ・ホールディングス・インコーポレーテッド 脊柱用スペーサ
US6037519A (en) * 1997-10-20 2000-03-14 Sdgi Holdings, Inc. Ceramic fusion implants and compositions
CA2280931C (fr) 1997-02-07 2009-05-05 Stryker Corporation Dispositif osteogeniques sans matrice, implants et methodes d'utilisation associees
US20010016646A1 (en) 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
US7041641B2 (en) 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
TW562807B (en) * 1997-04-01 2003-11-21 Chugai Pharmaceutical Co Ltd Novel secretory membrane protein
CA2291514C (fr) 1997-05-30 2011-07-12 Creative Biomolecules, Inc. Procedes pour evaluer la morphogenese des tissus et leur activite
US5972368A (en) * 1997-06-11 1999-10-26 Sdgi Holdings, Inc. Bone graft composites and spacers
US20020052026A1 (en) 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
US6511509B1 (en) 1997-10-20 2003-01-28 Lifenet Textured bone allograft, method of making and using same
AU1906599A (en) * 1997-12-09 1999-06-28 Ontogeny, Inc. Pancreatic-derived factors, and uses related thereto
US6027917A (en) 1997-12-10 2000-02-22 Genetics Institute, Inc. Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
US7147839B2 (en) 1998-05-29 2006-12-12 Curis, Inc. Methods for evaluating tissue morphogenesis and activity
EP1102568A1 (fr) 1998-08-06 2001-05-30 SDGI Holdings, Inc. Separateurs osseux intervertebraux composites
ES2326467T3 (es) 2000-12-08 2009-10-13 Osteotech, Inc. Implante para aplicaciones ortopedicas.
US6752831B2 (en) 2000-12-08 2004-06-22 Osteotech, Inc. Biocompatible osteogenic band for repair of spinal disorders
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
ATE386129T1 (de) * 2001-11-27 2008-03-15 Nexyte Ab Produktion eukaryontischer proteine und nukleinsäuremoleküle in c. elegans
CH695985A5 (de) 2002-01-21 2006-11-15 Straumann Holding Ag Oberflächenmodifizierte Implantate.
EP1504033A2 (fr) 2002-05-03 2005-02-09 Millenium Biologix Inc. Peptides stimulant un tissu conjonctif
CN1878565B (zh) 2003-09-12 2011-01-12 惠氏公司 用于递送成骨蛋白的注射型磷酸钙固体小棒剂和糊剂
PT1737734E (pt) 2004-03-10 2010-11-11 Scil Technology Gmbh Implantes revestidos, seu fabrico e utilização
CA2561317A1 (fr) 2004-03-26 2005-10-13 Acceleron Pharma Inc. Propeptides bmp-3 et methodes associees
AU2005247871A1 (en) 2004-04-27 2005-12-08 Research Development Foundation Antagonism of TGF-beta superfamily receptor signaling
WO2005113590A2 (fr) 2004-05-12 2005-12-01 Acceleron Pharma Inc. Propeptides de bmp10 et procédés correspondants
CA2567405A1 (fr) 2004-05-25 2005-12-08 Stryker Corporation Utilisation des proteines morphogeniques pour traiter les anomalies des cartilages
US7749268B2 (en) 2004-05-26 2010-07-06 Warsaw Orthopedic, Inc. Methods for treating the spine
AU2005258286A1 (en) 2004-06-24 2006-01-05 Acceleron Pharma Inc. GDF3 propeptides and related methods
ES2561048T3 (es) 2004-07-23 2016-02-24 Acceleron Pharma Inc. Polipéptidos del receptor ActRII
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
KR20160137665A (ko) 2005-11-23 2016-11-30 악셀레론 파마 인코포레이티드 액티빈-ａｃｔｒⅱａ 길항제 및 골 성장을 촉진하기 위한 이들의 용도
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
CA2641860C (fr) 2006-02-09 2015-07-14 Biomimetic Therapeutics, Inc. Compositions et methodes pour le traitement d'os
EP2035030A2 (fr) 2006-05-17 2009-03-18 Stryker Corporation Procédé pour traiter des défauts cartilagineux à l'aide d'un complexe de protèine morphogènique soluble
JP5484047B2 (ja) 2006-06-30 2014-05-07 バイオミメティック セラピューティクス， エルエルシー 回旋筋腱板傷害を処置するためのｐｄｇｆ−生体マトリックス組成物および方法
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
ES2447516T3 (es) 2006-12-21 2014-03-12 Stryker Corporation Formulaciones de liberación sostenida que comprenden cristales BMP-7
AU2008211007B2 (en) 2007-02-01 2013-09-19 Acceleron Pharma Inc. Activin-ActRIIa antagonists and uses for treating or preventing breast cancer
TW202021980A (zh) 2007-02-02 2020-06-16 美商艾瑟勒朗法瑪公司 衍生自ActRIIB的變體與其用途
CA3039330C (fr) 2007-02-09 2021-11-09 Acceleron Pharma Inc. Antagonistes de l'activine-actriia et utilisations pour la promotion de la croissance osseuse chez les patients cancereux
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
JP5323832B2 (ja) 2007-08-07 2013-10-23 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー 酸性水溶液中にｇｄｆ−５を含むタンパク質製剤
CN107412734A (zh) 2007-09-18 2017-12-01 阿塞勒隆制药公司 活化素‑actriia拮抗剂和减少或抑制fsh分泌的用途
JP2011514331A (ja) 2008-02-13 2011-05-06 キース フルスカ， 血管硬化症の治療における使用のためのｂｍｐ−７
CA2720845A1 (fr) 2008-04-14 2009-10-22 Advanced Technologies And Regenerative Medicine, Llc Formulations liquides tamponnees de gdf-5
JP5922928B2 (ja) 2008-08-14 2016-05-24 アクセルロン ファーマ， インコーポレイテッド 赤血球レベルを高めるためのｇｄｆトラップの使用
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
AU2009291828C1 (en) 2008-09-09 2016-03-17 Biomimetic Therapeutics, Llc Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
EP2387412A4 (fr) 2009-01-13 2013-04-03 Acceleron Pharma Inc Procédés permettant d'augmenter l'adiponectine
JP5819734B2 (ja) 2009-02-12 2015-11-24 ストライカー コーポレイションＳｔｒｙｋｅｒ Ｃｏｒｐｏｒａｔｉｏｎ ＴＧＦ−βスーパーファミリーメンバー含有タンパク質の最小に侵襲性の全身送達のための組成物および方法
CA2752157A1 (fr) 2009-02-12 2010-08-19 Stryker Corporation Administration peripherique de proteines et notamment de membres de la superfamille du tgf-.beta. pour traiter les maladies et troubles systemiques
WO2010110974A1 (fr) 2009-03-24 2010-09-30 Stryker Corporation Procédés et compositions pour l'ingénierie tissulaire
EP2440576A4 (fr) 2009-06-08 2013-11-20 Acceleron Pharma Inc Procédé visant à augmenter le nombre d'adipocytes thermogènes
WO2010144696A1 (fr) 2009-06-11 2010-12-16 Burnham Institute For Medical Research Différenciation dirigée de cellules souches
AU2010263182B2 (en) 2009-06-12 2016-05-12 Acceleron Pharma Inc. Truncated ActRIIB-Fc fusion proteins
US9399086B2 (en) 2009-07-24 2016-07-26 Warsaw Orthopedic, Inc Implantable medical devices
WO2011031856A1 (fr) 2009-09-09 2011-03-17 Stryker Corporation Bmp-7 à utiliser dans le traitement de la douleur induite par les lésions et les maladies d'articulation
ES2387379T3 (es) 2009-09-17 2012-09-21 Stryker Corporation Tampones para controlar el pH de las proteínas morfogenéticas óseas
CA2781152A1 (fr) 2009-11-17 2011-05-26 Acceleron Pharma Inc. Proteines actriib et variants et utilisations de celles-ci se rapportant a l'induction de l'utrophine pour une therapie de la dystrophie musculaire
EP2516456A1 (fr) 2009-12-22 2012-10-31 Stryker Corporation Variants de la bmp-7 dotés d'une immunogénicité réduite
JP6144049B2 (ja) 2010-02-22 2017-06-07 バイオミメティック セラピューティクス，リミテッド ライアビリティ カンパニー 腱障害を処置するための血小板由来成長因子組成物及び方法
WO2011139594A2 (fr) 2010-04-27 2011-11-10 Medtronic, Inc. Bourse artificielle pour administration de médicament intra-articulaire
CA2817008A1 (fr) 2010-11-08 2012-05-18 Acceleron Pharma Inc. Agents de liaison a actriia et leurs utilisations
US9809636B2 (en) 2012-04-06 2017-11-07 Acceleron Pharma Inc. Methods for increasing red blood cell levels comprising administering BMP9
US10034945B2 (en) 2012-07-13 2018-07-31 Trustees Of Tufts College Silk powder compaction for production of constructs with high mechanical strength and stiffness
ES2884095T3 (es) 2012-11-02 2021-12-10 Celgene Corp Antagonistas de activina-actrii y usos para el tratamiento de trastornos óseos y otros trastornos
WO2014172692A1 (fr) 2013-04-19 2014-10-23 Theracell, Inc. Fibres osseuses déminéralisées dotées d'une géométrie contrôlée
BR122023023170A2 (pt) 2014-06-13 2024-02-20 Acceleron Pharma Inc. Uso de um antagonista de actrii no tratamento ou prevenção de úlcera cutânea associada com beta-talassemia
GB201412290D0 (en) 2014-07-10 2014-08-27 Cambridge Entpr Ltd Novel use
MA41052A (fr) 2014-10-09 2017-08-15 Celgene Corp Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
MD4801C1 (ro) 2014-12-03 2022-10-31 Celgene Corporation Antagonişti ai activin-ActRII şi utilizarea lor pentru tratamentul sindroamelor mielodisplazice
WO2016123583A1 (fr) 2015-01-29 2016-08-04 Theracell, Inc. Composition de fibres osseuses déminéralisées pour utilisation en chirurgie minimalement invasive
CA2986753A1 (fr) 2015-06-17 2016-12-22 Warsaw Orthopedic, Inc. Implants comprenant un oxysterol et procedes d'utilisation
JP7025021B2 (ja) 2015-10-26 2022-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ 還元多糖および酸化多糖ならびにそれらの使用の方法
US10688222B2 (en) 2016-11-21 2020-06-23 Warsaw Orthopedic, Inc. Lyophilized moldable implants containing an oxysterol
US10639157B2 (en) 2017-03-14 2020-05-05 Theracell, Inc. Demineralized bone fiber composition for use in minimally invasive surgery
US11464888B2 (en) 2017-06-12 2022-10-11 Warsaw Orthopedic, Inc. Moldable formulations containing an oxysterol in an acellular tissue matrix
US11103618B2 (en) 2018-02-22 2021-08-31 Warsaw Orthopedic, Inc. Demineralized bone matrix having improved handling characteristics
US11498880B2 (en) 2019-07-26 2022-11-15 Warsaw Orthopedic, Inc. Calcium phosphate granules and methods of making them
CN113603792B (zh) * 2021-08-26 2023-06-30 深圳市人民医院 一种重组骨形态发生蛋白-2及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0536186B1 (fr) * 1990-05-16 2001-11-21 Genetics Institute, Inc. Proteines d'induction osseuse et cartilagineuse
DK0592562T3 (da) * 1991-06-25 1999-08-30 Genetics Inst BMP-9-præparater

Also Published As

Publication number Publication date
AU6910794A (en) 1994-12-12
KR100231640B1 (ko) 1999-12-01
ATE265529T1 (de) 2004-05-15
FI955420A0 (fi) 1995-11-10
CA2161807A1 (fr) 1994-11-24
DE69433742D1 (de) 2004-06-03
AU677849B2 (en) 1997-05-08
NO954525L (no) 1995-11-09
BR9406716A (pt) 1996-02-06
NO954525D0 (no) 1995-11-09
EP0698095A1 (fr) 1996-02-28
DE69433742T2 (de) 2005-07-07
WO1994026893A1 (fr) 1994-11-24
JPH09501305A (ja) 1997-02-10
KR960701997A (ko) 1996-03-28
FI955420A (fi) 1996-01-08
EP0698095B1 (fr) 2004-04-28

Similar Documents

Publication Publication Date Title
US5703043A (en) Bone morphogenetic protein-10 (BMP-10) compositions
EP0698095B1 (fr) Compositions de bmp-10
US5728679A (en) BMP-15 compositions
CA2161808C (fr) Compositions bmp-10
US20030149241A1 (en) Bone morphogenetic protein (BMP)-17 and BMP-18 compositions
EP1028744B1 (fr) Utilisations neuronales de bmp-11
AU2003244613B2 (en) Neuronal uses of BMP-11